Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program

CONCLUSION/RELEVANCEThe periprocedural complication risk for edoxaban treated patients undergoing pacemaker or invasive cardiac monitoring implantation was low. This population of patients was well managed in routine practice.This article is protected by copyright. All rights reserved

https://onlinelibrary.wiley.com/doi/10.1111/pace.14381?af=R

Source: Pacing and Clinical Electrophysiology : PACE - October 18, 2021 Category: Cardiology Authors: Martin Unverdorben, Christian Heymann, Amparao Santamaria, Manish Saxena, Thomas Vanassche, Robert Wilkins, James Jin, Cathy Chen, Paolo Colonna Tags: ORIGINAL ‐ DEVICES Source Type: research